Clinical Trial Update: Paricalcitol Trial: Phase II, Open Label Clinical Trial of Paricalcitol in Combination With Gemcitabine/ Nab-Paclitaxel Therapy in Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase II open-label trial evaluating paricalcitol in combination with gemcitabine/nab-paclitaxel for advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)
• Paricalcitol (paricalcitol)

Snippet

Sponsor: Cancer Trials Ireland | Conditions: Advanced Pancreatic Cancer | Phase 2 | Status: COMPLETED